Martinsried/Munich, October 1, 2008. MediGene AG (Frankfurt, Prime Standard: MDG) and three private investors have founded Immunocore Ltd, which will focus on the technology platform for monoclonal ...
MediGene Sells Licensee Rights to the Drug Oracea(R) to Galderma Laboratories; Milestone Payments Totalling Up To 32 Million Euros Martinsried/Munich July 31, 2008. MediGene AG (Frankfurt, Prime ...
Medigene has agreed to expand its nearly two-year-old, up-to-$1 billion-plus cancer immunotherapy collaboration with bluebird bio, saying today that the expansion could generate up to $509 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback